Healthcare professionals are essential in the early detection, reporting, and prevention of substandard and falsified (SF) medical products. This moderated session will highlight ongoing efforts by industry, educators, and public health leaders to enhance provider capacity and institutional response systems. Panelists will discuss initiatives to equip clinicians, pharmacists, and other health workers with the skills and tools needed for rapid identification and reporting of SF medicines. The session will also emphasize the role of multidisciplinary collaboration and continuous education in safeguarding patient safety and maintaining public trust in health systems.
Healthcare professionals are essential in the early detection, reporting, and prevention of substandard and falsified (SF) medical products. This moderated session will highlight ongoing efforts by industry, educators, and public health leaders to enhance provider capacity and institutional response systems. Panelists will discuss initiatives to equip clinicians, pharmacists, and other health workers with the skills and tools needed for rapid identification and reporting of SF medicines. The session will also emphasize the role of multidisciplinary collaboration and continuous education in safeguarding patient safety and maintaining public trust in health systems.
BESAFE2025 besafe@jh.eduTechnical Issues?
If you're experiencing playback problems, try adjusting the quality or refreshing the page.
Questions for Speakers?
Use the Q&A tab to submit questions that may be addressed in follow-up sessions.
